1CL Liang,TT Wang, K Luby-Phelps,et al. Mitochondria mass is low in mouse substantia nigra dopamine neurons:implications for Parkinson's disease[J]. Exp Neurol,2007,203(2) :370-380.
2M Vila, D Ramonet, C Perier. Mitochondrial alterations in Parkinson' s disease : new clues [ J ]. Neuroehem,2008,107 ( 2 ) : 317-328.
3CP Ramsey, BI Giasson. Role of mitochondrial dysfunction in Parkinson' s disease :implications for treatement [ J]. Drugs Aging,2007,24 (2) :95-105.
4Schapira AHV, Cooper JM, Dexter D, et al. Anatomic and disease specificity of NADH CoQ reductase deficiency in Parkinson' s disease [ J]. Neurochem, 1990,55:2142-2145.
5Schapira AHV. Mitochondrial involvement in Parkinson' s disease, Huntington' s disease,hereditary spastic paraplegia and Friendrich' s ataxia[ J]. Biochim Biophys ACTA, 1999,1410 : 159-170.
7S Vali, RB Mythri, B Jagatha, et al. Integrating glutathione metabolism and mitochondrial dysfunction with implications for Parkinson' disease : A dynamic model [ J ]. Neuroscience, 2007,149 ( 4 ) : 917- 930.
8Latha Devi,Vijayendran R, Badanvalu M,et al. Mitochondrial import and accumulation of a-synuclein impair complex I in human dopaminergie neuronal cultures and Parkinson disease brain [ J ].BiolChem, 2008,283 ; 9089 -9100.
9TB Sherer,JR Richardson,CM Testa, et al. Mechanism of toxicity of pesticides acting at complex I:relevance to environmental etiologies of Parkinson ' s disease [ J ].Neurochem, 2007,100 ( 6 ) : 1469-1479.
10Chen JY, Tsao GC, Zhao Q, et al. Differential cytotoxicity of Mn (II) and Mn(III) :special reference to mitoehondrial[ Fe-S] containing enzaymes [J]. Toxicology Applied Pha, 2001,175 ( 2 ) : 160- 168.
二级参考文献11
1Schapira AHV,Cooper JW,Dexter D,et al.Mitochondrial complex I deficiency in Parkinson's disease.J Neurol,1989,26: 719-723.
2Aomi Y,Chen CS,Nakada K,et al.Cytoplasmic transfer of platelet mtDNA-less Hela cells restores complete mitochondrial respiratory function.Biochem Biophys Res Commun,2001,280:265-273.
3Vives-Bauza C,Andreu Al,Manfredi G,et al.Sequence analysis of the entire mitochondrial genome in parkinson's disease.Biochem Biophys Res Commun,2002,290:1593-1601.
4Simon DK,Mayeux R,Marker K,et al.Mitochondrial DNA mutations in complex I and tRNA genes in parkinson's disease.Neurology,2000,54: 703-709.
5Human mitochondrial DNA revised Cambridge reference sequence Available from: URL:http://www.mitomap.com.
6Anderson S,Bankier AT,Barrell BG,et al.Sequence and organization of the human mitochondrial genome.Nature,1981,290:457-465.
8Tretter L,Sipos I,Adam-Vizi V.Initiation of neuronal damage by complex I deficiency and oxidative stress in Parkinson's disease.Neurochem Res,2004,29: 569-577.
9Orth M,Schapire AH.Mitochondrial involvement in parkinson's disease.Neurochem Int,2002,40:533-541.
10Jenner P,Olanow CW.Understanding cell death in parkinson's disease.Ann Neurol,1998,44 (3 Suppl 1):S72-S84.
7Isidoro A, Martinez M, Fernandez PL, et al. Alteration of the bioenergetic phenotvpe of mitochondrial is a hallmark of breast' gastric, lung and oesophageal cancer [J]. Bioehem J, 2004, 378 (Pt1): 17 - 20.
